TY  - JOUR 
AU  - García Marín, José Juan
AU  - Rodríguez Romero, Marta
AU  - Herráez Aguilar, Elisa
AU  - Arsensio Martín, Maitane
AU  - Ortiz-Rivero, Sara
AU  - Sánchez Martín, Anabel
AU  - Fabris, Luca
AU  - Briz Sánchez, Oscar
PY  - 2021
SN  - 0272-8087
UR  - http://hdl.handle.net/10366/163200
AB  - Hepatocellular carcinoma (HCC) is a malignancy with poor prognosis when diagnosed at advanced stages in which curative treatments are no longer applicable. A small group of these patients may still benefit from transarterial chemoembolization. The...
LA  - eng
PB  - Thieme Gruppe
KW  - Immunotherapy
KW  - Liver cancer
KW  - Multidrug resistance
KW  - Targeted therapy
KW  - Immunotherapy
KW  - Liver Neoplasms
KW  - Molecular Targeted Therapy
KW  - Multidrug Resistance-Associated Proteins
TI  - Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems
DO  - 10.1055/s-0041-1735631
T2  - Seminars in Liver Disease
VL  - 42
M2  - 087
ER  -